申请人:RECEPTOS LLC
                            
                            
                                公开号:US11530205B2
                            
                            
                                公开(公告)日:2022-12-20
                            
                            Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as products containing such compounds, and methods of their use and synthesis. Such compounds have the structure of Formula (I) below: (I) or pharmaceutically acceptable salts thereof, wherein A, J, W
1
, Y, Z, R
1
, R
2
, R
3
and R
4
are as defined herein.
                            本文提供了调节胰高血糖素样肽 1(GLP-1)受体的化合物、含有此类化合物的产品及其使用和合成方法。此类化合物具有下式 (I) 结构:(I) 或其药学上可接受的盐,其中 A、J、W
1
,Y,Z,R
1
, R
2
, R
3
和 R
4
如本文所定义。